Skip to content
Medical Health Aged Care

Dementia Australia honours George Negus AM

Dementia Australia 2 mins read

Dementia Australia acknowledges with sadness the death of Australian journalist, author and broadcaster George Negus AM of Alzheimer’s disease.

 

Dementia Australia CEO Professor Tanya Buchanan said we extend our sincere condolences to Kirsty Cockburn and his sons Serge and Ned Negus.

 

“Mr Negus was an icon for Australians and for Australian media. He generously contributed to raising awareness about dementia and the impact it has on individuals and their families.” Professor Buchanan said.

 

“Throughout their experience, Ms Cockburn and their sons have been tireless in continuing to raise awareness publicly and at all levels of government to ensure that all Australian’s impacted by dementia know they are not alone.”

 

Dementia Australia Ambassador Hamish Macdonald said: “George Negus was a giant of Australian journalism. He was also a mentor and a dear friend. I will miss him greatly.”

 

“I am feeling sad today, but also immensely lucky to have crossed paths along the way. He loved telling stories and he helped me get better at telling them too. Wishing Kirsty, Ned, Serge and the wider family all my love,” Mr Macdonald said.

 

“We thank and honour Mr Negus and his family for the difference they have made to the lives of people living with dementia, their families and carers. Vale George Negus AM,” Professor Buchanan said.

 

If this story has prompted any questions or concerns, please contact the National Dementia Helpline anytime on 1800 100 500 or visit dementia.org.au.

 

-Ends-

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Stephen O’Connell, Media and Communications Advisor Stephen.oconnell@dementia.org.au 0402 284 257

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.